ONZETRA® Xsail® (sumatriptan nasal powder)

Note: The Avanir License Agreement is expected to terminate on March 10, 2019. Optinose is evaluating options including seeking a new license partner.

Please see Instructions for Use, Important Safety Information, and full Prescribing Information at www.ONZETRAHCP.com.